β¨ Medicines Distribution Consent
7 FEBRUARY 2008 NEW ZEALAND GAZETTE, No. 17
395
Product:
Zeldox Titration Pack
Active Ingredients:
Ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40mg Ziprasidone
Ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60mg Ziprasidone
Ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80mg Ziprasidone
Dosage Form:
Capsule
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturers:
Heinrich Mack Nachf GmbH & Co KG, Illertissen, Germany
Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia
Dated this 1st day of February 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go809
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Erbitux
Active Ingredient:
Cetuximab 2mg/mL
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product:
Seroquel
Active Ingredient:
Quetiapine fumarate 115.13mg equivalent to 100mg quetiapine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturers:
AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Product:
Seroquel
Active Ingredient:
Quetiapine fumarate 172.69mg equivalent to 150mg quetiapine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturers:
AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Product:
Seroquel
Active Ingredient:
Quetiapine fumarate 230.26mg equivalent to 200mg quetiapine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturers:
AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Product:
Seroquel
Active Ingredient:
Quetiapine fumarate 28.78mg equivalent to 25mg quetiapine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturers:
AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Product:
Seroquel
Active Ingredient:
Quetiapine fumarate 345.39mg equivalent to 300mg quetiapine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturers:
AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Dated this 1st day of February 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go808
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2008, No 17
Gazette.govt.nz —
NZ Gazette 2008, No 17
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicine
π₯ Health & Social Welfare1 February 2008
Medicines Act 1981, Distribution Consent, New Medicine, Zeldox Titration Pack, Ziprasidone
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare1 February 2008
Medicines Act 1981, Distribution Consent, Changed Medicines, Erbitux, Cetuximab, Seroquel, Quetiapine
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate